Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) saw a significant growth in short interest in August. As of August 15th, there was short interest totalling 5,400 shares, a growth of 125.0% from the July 31st total of 2,400 shares. Based on an average trading volume of 2,172,900 shares, the short-interest ratio is presently 0.0 days.

Psykey Stock Performance

CEOS stock opened at $0.03 on Wednesday. Psykey has a 1-year low of $0.01 and a 1-year high of $0.05. The business has a fifty day moving average price of $0.03 and a 200-day moving average price of $0.02.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.